[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334758-105":59,"doc-detail-334758-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","pan-cancer-analysis-of-prognostic-and-immunological-role-of-il4i1-in-human-tumors-bulk-omics-research-and-single-cell-sequencing-validation","Pan-cancer analysis of prognostic and immunological role of IL4I1 in human tumors - bulk omics research and single cell sequencing validation","","Interleukin-4 inducible gene 1 (IL4I1) regulates tumor progression across many cancer types, yet its pan-cancer links to immune infiltration and patient prognosis were unclear. This study integrates TCGA and other public omics resources and clinical proteomics to assess IL4I1 expression, clinical associations, prognostic value, gene set enrichment, and immune-cell correlations, including IL4I1 methylation and survival. IL4I1 is frequently overexpressed and associates with overall survival and pathological stage, increased protein levels, macrophage infiltration, immune checkpoint gene expression, and drug response patterns. Single-cell sequencing further refines IL4I1 distribution in the tumor microenvironment.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/pan-cancer-analysis-of-prognostic-and-immunological-role-of-il4i1-in-human-tumors-bulk-omics-research-and-single-cell-sequencing-validation/334758/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/pan-cancer-analysis-of-prognostic-and-immunological-role-of-il4i1-in-human-tumors-bulk-omics-research-and-single-cell-sequencing-validation/334758.png","ImageObject",300,407,{"name":92,"@type":93},"Emma Wilson","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What does IL4I1 regulate in tumors, and why is it important for prognosis?","Question",{"text":112,"@type":113},"IL4I1 is described as regulating tumor progression in numerous cancer types and influencing patient outcomes. The study evaluates whether its expression relates to prognosis and immune infiltration across cancers.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which datasets and analyses were used to study IL4I1?",{"text":117,"@type":113},"The analysis uses data from TCGA, GTEx, UALCAN, CPTAC, GEO, cBioPortal, CancerSEA, and TIMER to examine expression, clinical features, prognostic effects, methylation links to survival, gene set enrichment, and immune-cell correlations. Drug correlations with 192 anticancer drugs were also analyzed.",{"name":119,"@type":110,"acceptedAnswer":120},"What were the key findings about IL4I1 expression and tumor immunity?",{"text":121,"@type":113},"IL4I1 is significantly overexpressed in most tumors and its imbalance correlates with overall survival and pathological stage. Total IL4I1 protein increases in cancer, IL4I1 function relates to immunomodulatory pathways, and tumor-associated macrophage infiltration correlates positively with IL4I1 expression; scRNA-seq shows IL4I1 enrichment in macrophages and varying expression across cell types.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334758,1790445497,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":31,"preview_page_count":4},3848291630094,"https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Research  \nPan‑cancer analysis of prognostic and immunological role of IL4I1 in human tumors: a bulk omics research and single cell sequencing validation  \nBin Chen1,5 · Yi Liu2 · Yuping He3,5 · Chenfu Shen4,5  \nReceived: 5 August 2023 / Accepted: 29 April 2024  \n© The Author(s) 2024 OPEN  \nAbstract  \nBackground Interleukin-4 inducible gene 1 (IL4I1) regulates tumor progression in numerous tumor types. However, its correlation with immune infiltration and prognosis of patients in a pan-cancer setting remains unclear.  \nMethods Data from the Cancer Genome Atlas (TCGA), Genotype-Tissue Expression (GTEx), UALCAN, Clinical Proteomic Tumor Analysis Consortium (CPTAC), Gene Expression Omnibus (GEO), cBioPortal, Cancer Single-cell State Atlas (CancerSEA), and Tumor IMmune Estimation Resource(TIMER) databases were used to evaluate IL4I1 expression, clinical features and prognostic effects, gene set enrichment, and correlation with immune cell infiltration, as well as the relationship between IL4I1 methylation and expression and survival prognosis. Correlations with 192 anticancer drugs were also analyzed.  \nResults IL4I1 was significantly overexpressed in the majority of tumors, and the imbalance of IL4I1 was significantly correlated with overall survival and pathological stage. Moreover, total IL4I1 protein was increased in cancer. Therefore, IL4I1 may be used as a prognostic biomarker or protective factor in numerous types of cancer. The methylation level of IL4I1 may also be used as a prognostic marker. The functional enrichment of IL4I1 was closely related to the immunomodulatory pathway. In addition, the level of tumor-associated macrophage infiltration was positively correlated with the expression of IL4I1 in pan-cancerous tissues. scRNA-seq analysis suggested that IL4I1 differ significantly among different cells in the tumor microenvironment and was most enriched in macrophages. Various immune checkpoint genes were positively correlated with IL4I1 expression in most tumors. In addition, patients with high IL4I1 expression may be resistant to BMS-754807 and docetaxel, but sensitive to temozolomide.  \nConclusion IL4I1 may play a role as promoter of cancer and prognostic indicator in patients. High expression of IL4I1 is associated with the state of tumor immunosuppression and may contribute to tumor-associated macrophage invasion. Therefore, IL4I1 may be a new therapeutic target for the treatment and prognosis of patients with cancer.  \nKeywords Interleukin-4 inducible gene 1 · Pan-cancer · Tumor immune microenvironment · Tumor immunosuppressive status · Tumor-associated macrophages  \nSupplementary Information The online version contains supplementary material available at [https://doi.org/10.1007/s12672-024-](https://doi.org/10.1007/s12672-024-)[ ](https://doi.org/10.1007/s12672-024-)[01000-5](01000-5.)[.](01000-5.)  \n* Yuping He, [ypinghe2022@126.com](ypinghe2022@126.com); * Chenfu Shen, [scf680524@csu.edu.cn |](scf680524@csu.edu.cn |1Department of Radiology)[1](scf680524@csu.edu.cn |1Department of Radiology)[Department of Radiology](scf680524@csu.edu.cn |1Department of Radiology), Xiangya Hospital, Central South University, Changsha, Hunan, China. 2Emergency Department, West China Hospital, Sichuan University, Chengdu, Sichuan, China. 3Health Management Center, Xiangya Hospital, Central South University, Changsha, Hunan, China. 4Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan, China. 5National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, China.  \nDiscover Oncology  \n(2024) 15:139  \n| [https://doi.org/10.1007/s12672-024-01000-5](https://doi.org/10.1007/s12672-024-01000-5)  \nAbbreviations  \nACC Adrenocortical carcinoma BLCA Bladder urothelial carcinoma BRCA Breast invasive carcinoma  \nCESC Cervical squamous cell carcinoma and endocervical adenocarcinoma CHOL Cholangiocarcinoma  \nCOAD Colon adenocarcinoma  \nDLBC Lymphoid neop","cbCaidTPvoh7fZ7j","https://ap.wps.com/l/cbCaidTPvoh7fZ7j","pdf",11014308,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction\n## IL4I1 biological functions and immune regulation","[{\"question\":\"What does IL4I1 regulate in tumors, and why is it important for prognosis?\",\"answer\":\"IL4I1 is described as regulating tumor progression in numerous cancer types and influencing patient outcomes. The study evaluates whether its expression relates to prognosis and immune infiltration across cancers.\"},{\"question\":\"Which datasets and analyses were used to study IL4I1?\",\"answer\":\"The analysis uses data from TCGA, GTEx, UALCAN, CPTAC, GEO, cBioPortal, CancerSEA, and TIMER to examine expression, clinical features, prognostic effects, methylation links to survival, gene set enrichment, and immune-cell correlations. Drug correlations with 192 anticancer drugs were also analyzed.\"},{\"question\":\"What were the key findings about IL4I1 expression and tumor immunity?\",\"answer\":\"IL4I1 is significantly overexpressed in most tumors and its imbalance correlates with overall survival and pathological stage. Total IL4I1 protein increases in cancer, IL4I1 function relates to immunomodulatory pathways, and tumor-associated macrophage infiltration correlates positively with IL4I1 expression; scRNA-seq shows IL4I1 enrichment in macrophages and varying expression across cell types.\"}]","Pan-cancer analysis of prognostic and immunological role of IL4I1 in human tumors - bulk omics research and single cell sequencing validation | PDF",1790008246]